COMPARISON OF LUNG RECRUITABILITY ASSESSMENT BY HYSTERESIS RATIO AND RECRUITMENT-TO-INFLATION RATIO, AND PEEP TITRATION IN ARDS. (PV-TOOL)

July 14, 2026 updated by: Oriol Roca

COMPARISON OF LUNG RECRUITABILITY ASSESSMENT BY HYSTERESIS RATIO AND RECRUITMENT-TO-INFLATION RATIO AND THE USE OF DIFFERENT PEEP TITRATION METHODS IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)

This multicenter, single-blind physiological study aims to compare two bedside methods for assessing lung recruitability in mechanically ventilated patients with acute respiratory distress syndrome (ARDS): the recruitment-to-inflation (R/I) ratio and the pressure-volume (PV) loop hysteresis ratio. Lung recruitability will be defined according to the reduction in lung collapse measured by electrical impedance tomography (EIT) during a standardized lung recruitment maneuver.

Following baseline measurements, participants will undergo sequential physiological assessments, including lung recruitability evaluation using both the R/I ratio and a low-flow PV loop, a standardized lung recruitment maneuver with a decremental PEEP trial, and a second PV loop performed at a lower maximum inflation pressure. The order of the R/I ratio assessment and the PV loop maneuver will be randomized.

In a final crossover phase, four different PEEP titration strategies will be evaluated in randomized order. Each strategy will be applied for 15 minutes and separated by a washout period at the patient's baseline clinical PEEP. Respiratory mechanics, gas exchange, ventilation/perfusion distribution, and hemodynamic variables will be assessed throughout the protocol.

The primary objective is to determine the agreement between the hysteresis ratio and the R/I ratio for identifying lung recruitability. Secondary objectives include evaluating whether a PV loop performed with a lower maximum pressure provides similar information on recruitability and comparing the physiological effects of different PEEP titration strategies. Approximately 30 patients with moderate-to-severe ARDS receiving invasive mechanical ventilation will be enrolled.

Study Overview

Detailed Description

Acute respiratory distress syndrome (ARDS) is a severe form of respiratory failure that requires mechanical ventilation. One of the main challenges in ventilator management is selecting the optimal level of positive end-expiratory pressure (PEEP), as patients differ in their potential for lung recruitment. Individualizing PEEP may help improve lung protection by reducing lung collapse while avoiding overdistension. The study is designed to improve the understanding of bedside tools for assessing lung recruitability and to evaluate their potential role in personalizing mechanical ventilation in patients with ARDS.

Patients meeting the inclusion criteria will be enrolled in this multicenter, single-blind physiological study after informed consent has been obtained. Continuous monitoring will include electrical impedance tomography (EIT), esophageal pressure, mechanical ventilation parameters, end-tidal carbon dioxide, and standard hemodynamic monitoring throughout the study protocol.

After enrollment, a fluid responsiveness assessment will be performed using a standardized tidal volume challenge to optimize hemodynamic conditions before study interventions. Baseline measurements will then be obtained after 15 minutes at the patient's clinical ventilator settings and will include respiratory mechanics, arterial blood gases, ventilation/perfusion (V/Q) analysis, and hemodynamic variables.

The primary endpoint is the comparison between the hysteresis ratio and the recruitment-to-inflation ratio for the assessment of lung recruitability, using the reduction in lung collapse measured by EIT as the reference standard. Secondary endpoints include comparison of recruitability assessment obtained with PV loops performed at maximum inflation pressures of 40 and 30 cmH₂O, and evaluation of the physiological effects of different PEEP titration methods on respiratory mechanics, ventilation/perfusion matching, gas exchange, and hemodynamics. Clinical outcomes, including duration of mechanical ventilation, ICU and hospital length of stay, and mortality, will also be recorded.

The first study phase evaluates lung recruitability using two bedside methods: the recruitment-to-inflation (R/I) ratio and a low-flow pressure-volume loop with a maximum pressure of 40 cmH₂O (PVloop40). The order of these two assessments will be computer-randomized. During the R/I assessment, measurements will be obtained at PEEP levels of 5 and 15 cmH₂O, followed by a single-breath maneuver to calculate the recruitment-to-inflation ratio. The PVloop40 maneuver will be used to calculate the hysteresis ratio from the inspiratory and expiratory limbs of the pressure-volume curve.

Following recruitability assessment, patients will undergo a standardized lung recruitment maneuver. PEEP will be progressively increased from 5 to 24 cmH₂O with intermediate stabilization periods to assess patient tolerance. After recruitment, respiratory mechanics, arterial blood gases, and hemodynamic measurements will be repeated at the highest PEEP level.

A decremental PEEP trial will subsequently be performed from 24 to 6 cmH₂O using 2 cmH₂O decrements maintained for at least 3 minutes each. Electrical impedance tomography data obtained during this maneuver will be used to quantify regional lung collapse and overdistension and to identify the optimal PEEP according to EIT-derived criteria. After completion of the decremental trial, a second low-flow pressure-volume loop with a maximum pressure of 30 cmH₂O (PVloop30) will be performed to determine whether recruitability can be accurately assessed using lower inflation pressures.

In the final phase, participants will undergo a randomized crossover comparison of four PEEP titration strategies: (1) transpulmonary pressure-guided PEEP, (2) EIT-guided PEEP, (3) R/I ratio-guided PEEP, and (4) compliance-guided PEEP. The order of the four strategies will be computer-generated. Each PEEP strategy will be maintained for 15 minutes, followed by assessment of respiratory mechanics, ventilation/perfusion matching, and hemodynamic variables. Between interventions, patients will return to their baseline clinical PEEP for a 15-minute washout period before initiation of the next strategy.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Intubated patients with acute respiratory distress syndrome (ARDS): PaO2/FiO2 ratio <200, with bilateral infiltrates of non-cardiogenic origin, with a PEEP of at least 5 cmH2O.
  • The patient is receiving mechanical ventilation and continuous sedation.
  • The patient has an esophageal balloon.
  • Written informed consent signed and dated by the patient or one relative in case the patient is unable to consent, after a full explanation of the study by the investigator and prior to study participation

Exclusion Criteria:

  • Patients with< 18 years old
  • Pregnant woman
  • Lung recruitment maneuvers are deemed unsafe by the medical team
  • Unable to fit EIT belt due to patient size
  • Contraindications to EIT monitoring (e.g. burns, pacemaker, thoracic wounds limiting electrode placement)
  • Hemodynamic instability (Systolic BP < 75 mmHg or MAP < 60 mmHg despite vasopressors and/or heart rate < 55 bpm)
  • Hypernatremia (Na+ >145mEq/L)
  • The formalized ethical decision to withhold or withdraw life support
  • Patient under guardianship
  • Patients deprived of liberties
  • Impossibility to give informed consent by both patient and family (i.e. language barrier)
  • Patient was already enrolled in the present study in a previous episode of acute respiratory failure.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Physiological study protocol
Participants undergo the complete physiological study protocol, including assessment of lung recruitability, standardized lung recruitment, decremental PEEP trial, and randomized crossover evaluation of four PEEP titration strategies. All participants receive every study intervention; only the order of selected procedures is randomized.
Participants undergo a standardized physiological protocol including lung recruitability assessment using the recruitment-to-inflation ratio and pressure-volume loop hysteresis ratio, a standardized lung recruitment maneuver, a decremental PEEP trial, and crossover evaluation of four PEEP titration strategies based on transpulmonary pressure, electrical impedance tomography, respiratory system compliance, and the recruitment-to-inflation ratio. The order of the recruitability assessments and PEEP titration strategies is randomized.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Agreement between the hysteresis ratio and the recruitment-to-inflation (R/I) ratio for assessing lung recruitability
Time Frame: During the study procedure (approximately within 2-3 hours after enrollment).
Agreement between lung recruitability assessed by the hysteresis ratio obtained from the pressure-volume loop and the recruitment-to-inflation (R/I) ratio, using the reduction in lung collapse measured by electrical impedance tomography (EIT) during the recruitment maneuver as the reference standard.
During the study procedure (approximately within 2-3 hours after enrollment).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Agreement between PVloop30 and PVloop40 for the assessment of lung recruitability
Time Frame: During the study procedure.
Comparison of lung recruitability assessment obtained from the hysteresis ratio measured using a low-flow pressure-volume loop with a maximum inflation pressure of 30 cmH₂O (PVloop30) and 40 cmH₂O (PVloop40), to determine whether a lower-pressure PV loop provides comparable information on lung recruitability
During the study procedure.
Respiratory mechanics and ventilation/perfusion (V/Q) changes according to different PEEP titration methods
Time Frame: During the study procedure, after 15 minutes of each randomized PEEP titration strategy
Comparison of respiratory mechanics and ventilation/perfusion (V/Q) distribution between four different PEEP titration strategies: transpulmonary pressure-guided PEEP, electrical impedance tomography-guided PEEP, recruitment-to-inflation ratio-guided PEEP, and respiratory system compliance-guided PEEP.
During the study procedure, after 15 minutes of each randomized PEEP titration strategy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

January 1, 2029

Study Registration Dates

First Submitted

July 14, 2026

First Submitted That Met QC Criteria

July 14, 2026

First Posted (Actual)

July 20, 2026

Study Record Updates

Last Update Posted (Actual)

July 20, 2026

Last Update Submitted That Met QC Criteria

July 14, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is no plan to make individual participant data available to other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Distress Syndrome (ARDS)

Clinical Trials on Physiological lung recruitability assessment and PEEP titration protocol

3
Subscribe